Abstract
Peanut allergy is a potentially life-threatening disease with substantial impact on the quality of life of patients and carers.1 Many initiatives are underway to develop treatment alternatives for strict peanut avoidance. Subcutaneous immunotherapy with aqueous peanut extract was found to be too dangerous.2 Alternatives such as sublingual, epicutaneous, and oral immunotherapies are being tested. So far, oral immunotherapy (OIT) has proved most effective in achieving meaningful desensitisation while on therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
